But unlike brand-name GLP-1s, they aren't Food and Drug Administration approved
Nikolic DGR, Rizvi AA, Patti AM, Montalto G, Maranta F, Cianflone D, Stoian AP, Rizzo M
Launch dates for the new system are shown below for the Highmark segments where we serve as a General Agency Distribution Channel: Pennsylvania (all regions) Launch on Monday, April 28 th , 2025 West Virginia Launch on Monday, April 14 th , 2025 If you are an NFP BNGA Producer Partner that relies on the support of our NFP BNGA team for renewal actions and New Business Quotes/Implementation through the system: This change will not impact you directly our team will continue to transact in the system on your behalf
(ii) Cu 2+ induces the secretion of acidic SMase from leukocytes which in turn leads to accumulation of erythrocytic ceramide [131] and (iii) treatment of erythrocytes with extracellular SMase resulted in ceramide-associated alterations in membrane-cytoskeleton interactions and membrane organization [125]
But they are prescription injectables and come with different risk profiles and medical oversight needs